Regeneron Pharmaceuticals Inc. buy Erntehelfer
Start price
06.08.21
/
50%
€508.90
Target price
06.08.22
-
Performance (%)
17.82%
End price
06.08.22
€599.60
Summary
This prediction ended on 06.08.22 with a price of €599.60. The BUY prediction by Erntehelfer finished with a performance of 17.82%. Erntehelfer has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -3.506% | -3.506% | 31.240% | -16.090% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% | 49.835% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% | 89.762% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% | 64.380% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% | 64.245% |
Comments by Erntehelfer for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Erntehelfer hat das Wertpapier Regeneron Pharmaceuticals Inc. in seinem Wikifolio Doppelanalyse (Chance) SL+ gekauft.
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Erntehelfer gewählte maximale Laufzeit wurde überschritten